2026-04-17T08:07:49Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1589512025-11-19T20:55:41Zcom_2072_1057col_2072_478917col_2072_478933

00925njm 22002777a 4500 dc de la Torre, Beatriz G. author Albericio Palomera, Fernando author 2020-05-06T15:36:26Z 2020-05-06T15:36:26Z 2018-02-27 2020-05-06T15:36:26Z This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules. Disseny de medicaments Pèptids Farmacologia Drug design Peptides Pharmacology The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules